News

  1. Genetic diversity could help protect against disease

    A team of researchers from the Leibniz-Institute of Freshwater Ecology and Inland Fisheries (IGB) has succeeded in demonstrating experimentally (in a lab) that genetic diversity makes populations more resistant to disease.

    Industry News 

    Read more »
  2. New study shows promise of permethrin-treated clothing

    The Entomological Society of America reports today that a new study from the CDC (Centre for Disease Control) in the USA shows that permethrin-treated clothing may stop ticks from biting. This will thus reduce transmission of diseases like Lyme disease. Lab tests showed germ-carrying ticks can't move properly after contact with treated garments, making them sluggish and likely interfering with their ability to bite. 

    Industry News

     

    Read more »
  3. Ingestible 'bacteria on a chip' could help diagnose disease

    Researchers have built an ingestible sensor equipped with genetically engineered bacteria that can diagnose bleeding in the stomach or other gastrointestinal problems. Ultra-low-power sensors carrying genetically engineered bacteria can detect gastric bleeding. 

    Industry News 

    Read more »
  4. Lower prices negotiated for 9 medicines

    Service Announcement for price changes to 12 medicines. For 9 medicines we have negotiated lower prices for patients, 3 medicines have increases. 

    TheSocialMedwork service online 

    Read more »
  5. Going mobile - making healthcare more patient focussed

    Mobile has revolutionised everyday life and now big pharma is using smartphones and other mobile devices to improve research and development.

    Mobile phone with TheSocialMedwork service being used 

    Read more »
  6. Superlative senior English-language copywriter sought

    Want to join a dynamic startup and make your work count? Join a dynamic, multicultural and mission-driven social impact startup with real potential.

    Lady sitting at computer

    Read more »
  7. Why is niraparib (Zejula) important for women with recurrent ovarian cancer?

    The European Medicines Agency has recently approved Niraparib (Zejula) for use in the European Union as a treatment for women struggling with a specific type of advanced ovarian cancer known as high-grade serous epithelial ovarian cancer, which includes cancers that affect the peritoneum and/or the fallopian tubes.

    smiling woman with friends 

    Read more »
  8. We're seeking a talented Director of Technology

    Vacancy to lead our technology team in growing and meeting the demands of a global, pioneering medical service. 

    Our future director examining our job 

    Read more »
  9. What’s the difference between a brand name and a generic medicine?

    brand name generic medicine
    When a new medicine gets approved for use and for sale in a specific region, it’s usually given a brand name by the pharmaceutical company who discovered or developed it.

    Read more »
  10. Preapproval vs unapproved or elsewhere approved medicines

    ‘Unapproved medicines’, ‘compassionate use’, ‘early access drugs’..

    preapproval vs unapproved

    Read more »
Posts loader

One more step before you can continue

Our service contains information about acquiring medicines that have been approved in another country. This includes professional information such as approval details, product information and pricing. By scrolling, you are declaring that you are requesting any such information.

Scroll down.

No, I'd like to receive general information only.

Disclaimer: The information TSM provides is aimed at patients with terminal and life-debilitating diseases, their doctors and healthcare professionals. It supports an informed decision by the treating doctor about the patient’s treatment and the consideration of a medicine which has not been approved in the patient’s country.